Use of targeted therapy in patients with metastatic renal cell carcinoma: clinical and economic impact in a Canadian real-life setting

INTRODUCTION: Outside of randomized controlled clinical trials, the understanding of the effectiveness and costs associated with targeted therapies for metastatic renal cell carcinoma (mrcc) is limited in Canada. The purpose of the present study was to use real-world prospective data to assess the e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: Nazha, S., Tanguay, S., Kapoor, A., Jewett, M., Kollmannsberger, C., Wood, L., Bjarnason, G., Heng, D., Soulières, D., Reaume, N., Basappa, N., Lévesque, E., Dragomir, A.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6291289/
https://ncbi.nlm.nih.gov/pubmed/30607126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.4103
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados